Highlighting the breakthroughs in the realm of infection prevention, the focus of this article lies on recent studies involving Mandimycin for hardy fungal infections, varying hospital Antimicrobial Resistance (AMR) trends, a six-month HIV treatment, global dilemmas around hepatitis testing, and the beginning of a Lassa fever vaccine trial.
Discovered by Dr. Zhuo Shang, Ph.D., Mandimycin, an…